• News
  • Anal Cancer
  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer of Unknown Primary
  • Cervical Cancer
  • Colon Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • GIST
  • Head & Neck Cancer
  • Hodgkins Lymphoma
  • Leukemia
    • Acute Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Mesothelioma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • MPN-PV-ET-MF
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Non Hodgkins Lymphoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Rectal Cancer
  • Sarcoma
  • Skin Care
  • Skin Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Triple Negative Breast Cancer
  • Uterine Cancer
  • About Us
  • Advertising
  • News
  • Newly Diagnosed
  • Treatment & Care
  • Survivorship
  • Join the Community
  • Newsletter

Gleevec

  • GIST – Gastrointestinal Stromal Tumors: Overview
    December 8, 2025

    GIST – Gastrointestinal Stromal Tumors: Overview

    Charles H. Weaver, MD
  • Treatment of Desmoid Tumors
    November 28, 2023

    Treatment of Desmoid Tumors

    Charles H. Weaver, MD
  • Iclusig (ponatinib) Treatment of Chronic Myelod Leukemia
    March 6, 2020

    Iclusig (ponatinib) Treatment of Chronic Myelod Leukemia

    Charles H. Weaver, MD
  • Two Year TKI Consolidation Allowed for TKI Cessation in Select Patients With CML
    May 7, 2019

    Two Year TKI Consolidation Allowed for TKI Cessation in Select Patients With CML

    Charles H. Weaver, MD
  • Understanding TKI Therapy and Drug Resistance in Chronic Myelogenous Leukemia
    May 3, 2019

    Understanding TKI Therapy and Drug Resistance in Chronic Myelogenous Leukemia

    Charles H. Weaver, MD
  • Sitemap
  • About Us
  • Advertising
  • Privacy Policy
 

Loading Comments...